---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-114481"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:41:23.180633+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Galecto appoints Dr. Amy Wechsler to Board of Directors effective October 11, 2024

## Summary
- Board expanded to seven members; Wechsler appointed as Class I director with term through 2027 annual meeting.
- Wechsler is board-certified in dermatology and psychiatry and serves on the Bausch Health board.
- She holds an M.D. from Cornell University Medical College and an M.B.A. from Columbia Business School (2024).
- Wechsler is independent under Nasdaq standards and will receive standard non-employee director compensation and equity.

## SEC filing metadata
- accession: 0000950170-24-114481
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/0000950170-24-114481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/glto-20241015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-114481
- JSON: https://secwatch.observer/filing/0000950170-24-114481.json
- Plain text: https://secwatch.observer/filing/0000950170-24-114481.txt

## Key facts
- Executive change
  Amy Wechsler was appointed as Director at Damora Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Amy Wechsler to join the Board, effective as of October 11, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/0000950170-24-114481-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.